Sex, race, ethnic representation in clinical trials of Covid

JAMA Network

About The Study: In this systematic review and meta-analysis of 122 U.S.-based COVID-19 clinical trials with 176,000 participants, female participants were underrepresented in treatment trials, Asian and Black participants were underrepresented in prevention trials, and Hispanic or Latino participants were overrepresented in treatment trials. Strategies to better ensure diverse representation in COVID-19 studies are needed, especially for prevention trials.

Authors: Hong Xiao, Ph.D., and Joseph M. Unger, Ph.D., M.S., of the Fred Hutchinson Cancer Center in Seattle, are the corresponding authors.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamainternmed.2022.5600)

/Public Release. This material from the originating organization/author(s) may be of a point-in-time nature, edited for clarity, style and length. The views and opinions expressed are those of the author(s).View in full here.